Status:
UNKNOWN
TMVP1-ICG Mapping in Laparoscopic SLN Detection in Cervical Cancer
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18-60 years
Phase:
PHASE1
Brief Summary
Sentinel lymph node (SLN) mapping is an acceptable surgical strategy determine whether to perform radical lymphadenectomy in patients with early-stage cervical cancer. Investigators aim to determine t...
Eligibility Criteria
Inclusion
- At least 18 years of age, married, without childbearing requirements at the time of consent.
- FIGO stage IA1-IIB cervical squamous cell cancer and is a candidate for laparoscopy intervention, with lymph node dissection being a part of the surgical plan.
- Subject has provided written informed consent.
Exclusion
- Breast-feeding or pregnant
- Ongoing participation in another clinical trial with an investigational drug with 3 months
- Own allergy towards ICG and/or alcohol
- Diagnosis of bacterial vaginosis, fungal vaginitis, sexually transmitted diseases
- Patients with cardiac dysfunction or hepatic insufficiency or renal insufficiency
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03320772
Start Date
May 1 2017
End Date
May 1 2019
Last Update
October 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical Colledge, HUST
Wuhan, Hubei, China, 430030